High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis

Rheumatology (Oxford). 2018 Dec 1;57(12):2244-2246. doi: 10.1093/rheumatology/key234.

Mark Ford¹, Ilfita Sahbudin^{1

2

3}, Andrew Filer^{1

2

3}, Neil Steven^{4

5}, Benjamin A Fisher^{1

2

3}

¹ Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² Rheumatology Research Group, Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
³ National Institute for Health Research, Birmingham Biomedical Research Centre, Birmingham, UK.
⁴ CR-UK Clinical Trials Unit, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
⁵ Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

No abstract available

Publication types